Cargando…

Age-Restriction of a Validated Risk Scoring Tool Better Predicts HIV Acquisition in South African Women: CAPRISA 004

We examined the predictive ability of the VOICE risk screening tool among adolescent girls and young women at heightened HIV risk in urban and peri-urban Kwa-Zulu-Natal, South Africa. Using participant data from CAPRISA 004’s control arm (N = 444), we applied the initial VOICE risk screening score (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castor, Delivette, Burgess, Emma K., Yende-Zuma, Nonhlanhla, Heck, Craig J., Abdool Karim, Quarraisha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474358/ https://www.ncbi.nlm.nih.gov/pubmed/35419667 http://dx.doi.org/10.1007/s10461-022-03664-y

Ejemplares similares

Women with Pregnancies Had Lower Adherence to 1% Tenofovir Vaginal Gel as HIV Preexposure Prophylaxis in CAPRISA 004, a Phase IIB Randomized-Controlled Trial
por: Matthews, Lynn T., et al.
Publicado: (2013)

Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial
por: Succop, Stacey M., et al.
Publicado: (2014)

Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial
por: Karim, Quarraisha Abdool, et al.
Publicado: (2011)

Assessing Adherence in the CAPRISA 004 Tenofovir Gel HIV Prevention Trial: Results of a Nested Case–Control Study
por: MacQueen, Kathleen M., et al.
Publicado: (2014)

No Evidence for Selection of HIV-1 with Enhanced Gag-Protease or Nef Function among Breakthrough Infections in the CAPRISA 004 Tenofovir Microbicide Trial
por: Chopera, Denis R., et al.
Publicado: (2013)

CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women
por: Gengiah, Tanuja Narayansamy, et al.
Publicado: (2022)

Infrequent, low magnitude HIV-specific T cell responses in HIV-uninfected participants in the 1% tenofovir microbicide gel trial (CAPRISA004)
por: Burgers, WA, et al.
Publicado: (2012)

Ex vivo HIV entry into blood CD4+ T cells does not predict heterosexual HIV acquisition in women
por: Joag, Vineet, et al.
Publicado: (2018)

HIV prevalence among high school learners - opportunities for schools-based HIV testing programmes and sexual reproductive health services
por: Kharsany, Ayesha BM, et al.
Publicado: (2012)

Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trial
por: Mahomed, Sharana, et al.
Publicado: (2019)

Establishing a Cohort at High Risk of HIV Infection in South Africa: Challenges and Experiences of the CAPRISA 002 Acute Infection Study
por: van Loggerenberg, Francois, et al.
Publicado: (2008)

High incidence and persistence of hepatitis B virus infection in individuals receiving HIV care in KwaZulu-Natal, South Africa
por: Msomi, Nokukhanya, et al.
Publicado: (2020)

HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition
por: Liebenberg, Lenine J. P., et al.
Publicado: (2019)

Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial
por: Mahomed, Sharana, et al.
Publicado: (2023)

Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women
por: McKinnon, Lyle R., et al.
Publicado: (2018)

Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial
por: Mahomed, Sharana, et al.
Publicado: (2020)

High mortality rates in men initiated on anti-retroviral treatment in KwaZulu-Natal, South Africa
por: Naidoo, Kogieleum, et al.
Publicado: (2017)

Implementation of Adolescent-Friendly Voluntary Medical Male Circumcision Using a School Based Recruitment Program in Rural KwaZulu-Natal, South Africa
por: Montague, Carl, et al.
Publicado: (2014)

Enhancing oral PrEP uptake among adolescent girls and young women in Africa
por: Heck, Craig J., et al.
Publicado: (2022)

Integrated provision of topical pre‐exposure prophylaxis in routine family planning services in South Africa: a non‐inferiority randomized controlled trial
por: Mansoor, Leila E, et al.
Publicado: (2019)

Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol
por: Naidoo, Kogieleum, et al.
Publicado: (2017)

Correction to: Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol
por: Naidoo, Kogieleum, et al.
Publicado: (2019)

Pregnancy rates and outcomes in a longitudinal HIV cohort in the context of evolving antiretroviral treatment provision in South Africa
por: Naicker, Nivashnee, et al.
Publicado: (2022)

A retrospective cohort study of body mass index and survival in HIV infected patients with and without TB co-infection
por: Naidoo, Kogieleum, et al.
Publicado: (2018)

Case report: mechanisms of HIV elite control in two African women
por: Moosa, Yumna, et al.
Publicado: (2018)

Mortality in HIV and tuberculosis patients following implementation of integrated HIV-TB treatment: Results from an open-label cluster-randomized trial
por: Naidoo, Kogieleum, et al.
Publicado: (2022)

Prevalence and correlates of prescription drug diversion and misuse among people living with HIV in the eThekwini district, KwaZulu-Natal, South Africa
por: Chibi, Buyisile, et al.
Publicado: (2020)

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
por: Karim, Salim S Abdool, et al.
Publicado: (2021)

OR7-004 – Validation of AIDAI score
por: Piram, M, et al.
Publicado: (2013)

Recurrent Subclinical Tuberculosis Among Antiretroviral Therapy–Accessing Participants: Incidence, Clinical Course, and Outcomes( )
por: Naidoo, Kogieleum, et al.
Publicado: (2022)

Mortality and treatment response amongst HIV-infected patients 50 years and older accessing antiretroviral services in South Africa
por: Dawood, Halima, et al.
Publicado: (2018)

Identification of adolescent girls and young women for targeted HIV prevention: a new risk scoring tool in KwaZulu Natal, South Africa
por: Ayton, Sarah Gabrielle, et al.
Publicado: (2020)

Current status of the HIV epidemic & challenges in prevention
por: Karim, Quarraisha Abdool
Publicado: (2017)

Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention
por: Mahomed, Sharana, et al.
Publicado: (2022)

Epigenetic Regulation of BST-2 Expression Levels and the Effect on HIV-1 Pathogenesis
por: Singh, Ravesh, et al.
Publicado: (2021)

Identifying SARS-CoV-2 infections in South Africa: Balancing public health imperatives with saving lives
por: Baxter, Cheryl, et al.
Publicado: (2021)

Trends in HIV Prevention, Treatment, and Incidence in a Hyperendemic Area of KwaZulu-Natal, South Africa
por: Kharsany, Ayesha B. M., et al.
Publicado: (2019)

HIV treatment outcomes among people with initiation CD4 counts >500 cells/µL after implementation of Treat All in South African public clinics: a retrospective cohort study
por: Dorward, Jienchi, et al.
Publicado: (2020)

An Evaluation to Determine the Strongest CD4 Count Covariates during HIV Disease Progression in Women in South Africa
por: Tinarwo, Partson, et al.
Publicado: (2019)

Genital—Systemic Chemokine Gradients and the Risk of HIV Acquisition in Women
por: Liebenberg, Lenine J. P., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s4t0vkp2551fv8vu8nub207cml